Biotechnology Analysis & Statistics, July 2014 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: biotech, protein, biomedical, more »

31-60 of about 2 400 reports

Purchase Reports From Reputable Market Research Publishers

Global Synthetic Biology Market 2014-2018

Global Synthetic Biology Market 2014-2018

  • $ 2 500
  • Industry report
  • July 2014
  • by Infiniti Research Limited

About Synthetic Biology The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : World
Analysis of the US Molecular Imaging Informatics Market

Analysis of the US Molecular Imaging Informatics Market

  • $ 2 500
  • Industry report
  • July 2014
  • by Frost & Sullivan

Growth Opportunities in Nuclear and PET Imaging Informatics Subsist Despite Downward Pressures on Equipment Markets This study provides an analysis of the US market for molecular imaging informatics solutions ...

  • Industries : Genomics
  • Countries : United States
Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...

  • Industries : Biological Therapy
  • Countries : United States
BioChips & BioMEMS 2014

BioChips & BioMEMS 2014

  • $ 2 450
  • Industry report
  • July 2014
  • by Dedalus Consulting

BioChips & BioMEMS (Bio Microelectromechanical Systems)-World Markets, Applications & Opportunities: 2013-2018 Analysis & Forecasts A detailed report analyzing current trends in the dynamic and growing ...

  • Industries : Genomics
  • Countries : World
Global and China Stem Cell Industry Report, 2014-2017

Global and China Stem Cell Industry Report, 2014-2017

  • $ 2 250
  • Industry report
  • September 2014
  • by Research In China

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment ...

  • Industries : Biological Therapy
  • Countries : China, World
2014 Deep Research Report on Global and China Docosahexaenoic Acid (DHA) Industry

2014 Deep Research Report on Global and China Docosahexaenoic Acid (DHA) Industry

  • $ 2 200
  • Industry report
  • August 2014
  • by QY Research Group

Summary "2014 Deep Research Report on Global and China Docosahexaenoic Acid (DHA) Industry" was professional and depth research report on Global and China Docosahexaenoic Acid (DHA) industry. The report ...

  • Industries : Biotechnology
  • Countries : China, World
Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Growth Hormone Deficiency - Pipeline Review, H2 2014

Growth Hormone Deficiency - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • August 2014
  • by Global Markets Direct

Growth Hormone Deficiency - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H2 2014', provides an overview of the Growth Hormone Deficiency's therapeutic ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Genetic Disorders Partnering Terms and Agreements

Genetic Disorders Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Genetic Disorders Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter genetic disorders partnering deals. The majority of deals are ...

  • Industries : Genetically Modified Organism, Gmo
Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Opthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter opthalmics partnering deals. The majority of deals are discovery, preclinical ...

  • Industries : Biological Therapy
Pain Partnering 2009-2014

Pain Partnering 2009-2014

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Pain Partnering 2009-2014 provides understanding and access to the pain partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of ...

  • Industries : Biotechnology
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

  • $ 1 899
  • Industry report
  • August 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage ...

  • Industries : Biopharmaceutical
  • Countries : United States
Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Biopharmaceutical
Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 120 companies plus partners developing 107 gene therapy drugs in 276 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Biological Therapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 332 companies plus partners developing 441 Androgen Receptor drugs in 1457 developmental projects in cancer. ...

  • Industries : Biological Therapy
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 371 companies plus partners developing 642 EGFR1 pathway targeting drugs in 2397 developmental projects in cancer. ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 119 companies plus partners ...

  • Industries : Biological Therapy
Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 252 companies plus partners ...

  • Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 246 companies plus partners developing ...

  • Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 287 companies plus partners developing 411 TGF-beta receptor pathway targeting drugs in 1411 developmental ...

  • Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 366 companies plus partners developing 550 TNF-alpha pathway targeting drugs in 2048 developmental ...

  • Industries : Biological Therapy
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors of breast, colon, pancreas, liver and bone. There are today 179 companies plus partners ...

  • Industries : Biological Therapy
Cancer Stem Cells Drug Pipeline Update 2014

Cancer Stem Cells Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

  • Industries : Biological Therapy
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...

  • Industries : Biological Therapy
Antibodies in Oncology: Drug Pathway Analyzer 2014

Antibodies in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 608 antibody drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Biopharmaceutical
Global Bioinformatics Market Outlook 2019

Global Bioinformatics Market Outlook 2019

  • $ 1 600
  • Industry report
  • September 2014
  • by RNCOS

The Bioinformatics market has risen exponentially in recent years into an important segment of the biotechnology industry. The increasing application of genomics, proteomics, cheminformatics, transcriptomics, ...

  • Industries : Genomics
  • Countries : World
NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014

NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the NGM Biopharmaceuticals, ...

  • Industries : Biopharmaceutical
  • Countries : World
TARIS BioMedical, Inc. - Product Pipeline Review - 2014

TARIS BioMedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • September 2014
  • by Global Markets Direct

TARIS BioMedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘TARIS BioMedical, Inc. - Product Pipeline Review - 2014', provides an overview of the TARIS BioMedical, Inc.'s ...

  • Industries : Biopharmaceutical
  • Countries : World
Global Gene Therapy Market Outlook 2018

Global Gene Therapy Market Outlook 2018

  • $ 1 500
  • Industry report
  • September 2014
  • by RNCOS

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the ...

  • Industries : Biological Therapy
  • Countries : World
About 6 800 reports

Download Unlimited Documents from Trusted Public Sources

Global Vaccine Industry

  • Public Health
  • October 2014
    91 pages
  • Vaccine  

  • United States  

    World  

View report >

Global Vaccine Industry

September 2014

Vaccine Market In The Us

September 2014

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Life Technologies Corp.

United States

Abbott Laboratories

United States

Biogen Idec

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.